NDC 73475-3102
VYVGART Hytrulo 180 mg per 1 mL / 2000 U per 1 mL injection, solution
On the label: argenx US.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Avid Bioservices Inc. | Tustin, CA, United States | Makes the active ingredient | No problems foundMay 29, 2025 · 7 inspections |
| Catalent Indiana, LLC | Bloomington, IN, United States | Makes the active ingredient | Serious problems, FDA actionApr 24, 2026 · 10 inspections, 2 with FDA action |
| Patheon Italia S.p.A | Ferentino, Italy | Makes it | Problems found, fixed voluntarilyFeb 25, 2022 · 7 inspections, 1 with FDA action |
Product details
- Generic drug
- Efgartigimod Alfa and Hyaluronidase (human Recombinant): every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 180 mg per 1 mL / 2000 U per 1 mL
- Approval
- BLA BLA761304
- On the market since
- Jun 20, 2023
- Package NDCs
73475-3102-3- Official label
- DailyMed (National Library of Medicine), updated Jul 15, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?